BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND RAD21, HR21, 5885, ENSG00000164754, KIAA0078, FLJ25655, hHR21, MCD1, O60216, NXP1, HRAD21, FLJ40596, SCC1 AND Treatment
12 results:

  • 1. Comprehensive genomic profiling to identify actionable alterations for breast cancer brain metastases in the Chinese population.
    Lu Q; Wang N; Jiang K; Zhou H; Zhang P; Zhang J; Wang S; Sun P; Xu F
    ESMO Open; 2024 Mar; 9(3):102389. PubMed ID: 38460250
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Molecular Profile and Matched Targeted Therapy for Advanced breast cancer Patients.
    Falcone R; Lombardi P; Filetti M; Fabi A; Altamura V; Scambia G; Daniele G
    Curr Oncol; 2023 Feb; 30(2):2501-2509. PubMed ID: 36826152
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Comprehensive molecular profiling broadens treatment options for breast cancer patients.
    Kawaji H; Kubo M; Yamashita N; Yamamoto H; Kai M; Kajihara A; Yamada M; Kurata K; Kaneshiro K; Harada Y; Hayashi S; Shimazaki A; Mori H; Akiyoshi S; Oki E; Oda Y; Baba E; Mori M; Nakamura M
    Cancer Med; 2021 Jan; 10(2):529-539. PubMed ID: 33274848
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Microarray and RNA in situ hybridization assay for recurrence risk markers of breast carcinoma and ductal carcinoma in situ: Evidence supporting the use of diverse pathways panels.
    Evans MF; Vacek PM; Sprague BL; Stein GS; Stein JL; Weaver DL
    J Cell Biochem; 2020 Feb; 121(2):1736-1746. PubMed ID: 31595577
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Impact of Insurance Status on Radiation treatment Modality Selection Among Potential Candidates for Prostate, breast, or Gynecologic Brachytherapy.
    Grant SR; Walker GV; Koshy M; Shaitelman SF; Klopp AH; Frank SJ; Pugh TJ; Allen PK; Mahmood U
    Int J Radiat Oncol Biol Phys; 2015 Dec; 93(5):968-75. PubMed ID: 26452570
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Extreme chromosomal instability forecasts improved outcome in ER-negative breast cancer: a prospective validation cohort study from the TACT trial.
    Jamal-Hanjani M; A'Hern R; Birkbak NJ; Gorman P; Grönroos E; Ngang S; Nicola P; Rahman L; Thanopoulou E; Kelly G; Ellis P; Barrett-Lee P; Johnston SR; Bliss J; Roylance R; Swanton C
    Ann Oncol; 2015 Jul; 26(7):1340-6. PubMed ID: 26003169
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. A siRNA screen identifies rad21, EIF3H, CHRAC1 and TANC2 as driver genes within the 8q23, 8q24.3 and 17q23 amplicons in breast cancer with effects on cell growth, survival and transformation.
    Mahmood SF; Gruel N; Chapeaublanc E; Lescure A; Jones T; Reyal F; Vincent-Salomon A; Raynal V; Pierron G; Perez F; Camonis J; Del Nery E; Delattre O; Radvanyi F; Bernard-Pierrot I
    Carcinogenesis; 2014 Mar; 35(3):670-82. PubMed ID: 24148822
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Cohesin is required for activation of MYC by estradiol.
    McEwan MV; Eccles MR; Horsfield JA
    PLoS One; 2012; 7(11):e49160. PubMed ID: 23145106
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Enhanced rad21 cohesin expression confers poor prognosis in BRCA2 and BRCAX, but not BRCA1 familial breast cancers.
    Yan M; Xu H; Waddell N; Shield-Artin K; Haviv I; ; McKay MJ; Fox SB
    Breast Cancer Res; 2012 Apr; 14(2):R69. PubMed ID: 22537934
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Genome-wide functional screen identifies a compendium of genes affecting sensitivity to tamoxifen.
    Mendes-Pereira AM; Sims D; Dexter T; Fenwick K; Assiotis I; Kozarewa I; Mitsopoulos C; Hakas J; Zvelebil M; Lord CJ; Ashworth A
    Proc Natl Acad Sci U S A; 2012 Feb; 109(8):2730-5. PubMed ID: 21482774
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Selective recruitment of breast cancer anti-estrogen resistance genes and relevance for breast cancer progression and tamoxifen therapy response.
    van Agthoven T; Sieuwerts AM; Meijer D; Meijer-van Gelder ME; van Agthoven TL; Sarwari R; Sleijfer S; Foekens JA; Dorssers LC
    Endocr Relat Cancer; 2010 Mar; 17(1):215-30. PubMed ID: 19966015
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Centriole separation in DNA damage-induced centrosome amplification.
    Saladino C; Bourke E; Conroy PC; Morrison CG
    Environ Mol Mutagen; 2009 Oct; 50(8):725-32. PubMed ID: 19274769
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.